| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043586350 |
| P356 | DOI | 10.1007/S00213-004-2087-0 |
| P698 | PubMed publication ID | 15682306 |
| P5875 | ResearchGate publication ID | 8050488 |
| P50 | author | Mary Jeanne Kreek | Q21531361 |
| P2093 | author name string | Yong Zhang | |
| Eduardo R Butelman | |||
| Ann Ho | |||
| Stefan D Schlussman | |||
| P2860 | cites work | Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist | Q24535736 |
| Role of the serotonin 5-HT(2A) receptor in learning | Q24685023 | ||
| U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking | Q28141311 | ||
| Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations | Q28238385 | ||
| Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats | Q29619737 | ||
| Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor | Q35082154 | ||
| Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway | Q36877274 | ||
| Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A. | Q40585107 | ||
| Effect of acute binge cocaine on levels of extracellular dopamine in the caudate putamen and nucleus accumbens in male C57BL/6J and 129/J mice | Q42514157 | ||
| Effects of cyclazocine on cocaine self-administration in rats | Q42538794 | ||
| Effects of delta9-THC and WIN-55,212-2 on place preference in the water maze in rats | Q42691076 | ||
| Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated | Q43705022 | ||
| Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. | Q43740337 | ||
| Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats | Q43967913 | ||
| Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats | Q44149198 | ||
| The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference | Q44331723 | ||
| Kappa opioid inhibition of morphine and cocaine self-administration in rats | Q44333113 | ||
| Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies | Q44334428 | ||
| Distribution of kappa opioid receptor mRNA in adult mouse brain: an in situ hybridization histochemistry study | Q44335388 | ||
| The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. | Q44340372 | ||
| kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. | Q44341698 | ||
| The plant-derived hallucinogen, salvinorin A, produces ?-opioid agonist-like discriminative effects in rhesus monkeys | Q44343280 | ||
| Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice | Q44344098 | ||
| Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice | Q44344105 | ||
| Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice | Q44345333 | ||
| Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists | Q44345690 | ||
| Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo | Q44346801 | ||
| Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice | Q44347468 | ||
| Study of the behavioural responses related to the potential addictive properties of MDMA in mice | Q44752927 | ||
| The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. | Q46029870 | ||
| Involvement of the serotonergic neuronal system in phencyclidine-induced place aversion in rats | Q48119534 | ||
| Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: an in vivo microdialysis study | Q48183725 | ||
| Kappa agonist-induced reduction in dopamine release: site of action and tolerance | Q48417686 | ||
| LSD produces conditioned place preference in male but not female fawn hooded rats. | Q50911693 | ||
| LSD produces place preference and flavor avoidance but does not produce flavor aversion in rats. | Q52201169 | ||
| Aversive effects of the synthetic cannabinoid CP 55,940 in rats. | Q52202419 | ||
| Conditioned aversion to saccharin by single administrations of mescaline and d-amphetamine | Q70636707 | ||
| P433 | issue | 3 | |
| P921 | main subject | putamen | Q550934 |
| P304 | page(s) | 551-558 | |
| P577 | publication date | 2005-01-29 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors | |
| P478 | volume | 179 |
| Q24642017 | 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A |
| Q64105404 | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists |
| Q35837572 | A single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats |
| Q33817945 | Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys |
| Q39141647 | Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats |
| Q46880304 | Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat. |
| Q37251441 | Bidirectional translational research: Progress in understanding addictive diseases |
| Q38902043 | Clerodane diterpenes: sources, structures, and biological activities |
| Q28275440 | Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity |
| Q28307145 | Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats |
| Q64111902 | Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs |
| Q47871946 | Depressant Effects of Salvia divinorum Involve Disruption of Physiological Sleep. |
| Q33951137 | Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens |
| Q52602721 | Dezocine Alleviates Morphine-Induced Dependence in Rats. |
| Q38862468 | Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions |
| Q38276410 | Does the kappa opioid receptor system contribute to pain aversion? |
| Q30447153 | Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans |
| Q24616738 | Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects |
| Q24650168 | Dynorphin, stress, and depression |
| Q34493780 | Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats. |
| Q36979184 | Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum |
| Q36063630 | Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers |
| Q35776817 | Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats |
| Q42600971 | Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice |
| Q98464765 | Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain |
| Q37286215 | Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen |
| Q37072200 | Exposure to chronic mild stress prevents kappa opioid-mediated reinstatement of cocaine and nicotine place preference |
| Q36930731 | Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats |
| Q47988659 | Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. |
| Q33269030 | Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement |
| Q24631675 | Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines |
| Q34949512 | Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum |
| Q36977483 | Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. |
| Q57476500 | Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents |
| Q28075656 | Kappa Opioids, Salvinorin A and Major Depressive Disorder |
| Q34453709 | Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents |
| Q37309739 | Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion |
| Q34632744 | Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats. |
| Q37235834 | Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism |
| Q30490227 | Metabolic changes in the rodent brain after acute administration of salvinorin A. |
| Q37355904 | Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse |
| Q30467220 | Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A |
| Q37660087 | New therapeutic potential for psychoactive natural products |
| Q33725088 | Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace |
| Q57498472 | Opioid modulation of cognitive impairment in depression |
| Q34747694 | Opioid receptors and legal highs: Salvia divinorum and Kratom |
| Q30565476 | Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids. |
| Q37141902 | Pharmacological activation of kappa opioid receptors: aversive effects in adolescent and adult male rats |
| Q37987431 | Pharmacological activity of salvinorin A, the major component of Salvia divinorum |
| Q24656590 | Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents |
| Q46251268 | Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence |
| Q34061067 | Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects |
| Q38829394 | Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice: strain and heroin effects |
| Q38600702 | Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and Without Cocaine Dependence |
| Q33848200 | Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats |
| Q44641835 | Salvia divinorum use and phenomenology: results from an online survey |
| Q38652778 | Salvia divinorum: An overview of the usage, misuse, and addiction processes |
| Q38116484 | Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug |
| Q90191903 | Salvinorin A Does Not Affect Seizure Threshold in Mice |
| Q34401390 | Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse. |
| Q30439719 | Salvinorin A analogs as probes in opioid pharmacology |
| Q37349384 | Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence |
| Q26781580 | Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders |
| Q34144003 | Sex differences in kappa opioid pharmacology |
| Q44349818 | Sigma-1 receptor function is critical for both the discriminative stimulus and aversive effects of the kappa-opioid receptor agonist U-50488H. |
| Q36470824 | Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake |
| Q36605476 | Stress-Induced Enhancement of Ethanol Intake in C57BL/6J Mice with a History of Chronic Ethanol Exposure: Involvement of Kappa Opioid Receptors |
| Q52317568 | Structurally-Related Kappa Opioid Receptor Agonists with Substantial Differential Signaling Bias: Neuroendocrine and Behavioral Effects in C57BL6 Mice. |
| Q34510909 | Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors |
| Q47878237 | The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects. |
| Q28249800 | The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo |
| Q37946259 | The dynorphin/κ-opioid receptor system and its role in psychiatric disorders |
| Q36110480 | The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us? |
| Q34478698 | The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum |
| Q34650892 | The kappa opioid receptor: from addiction to depression, and back. |
| Q33890721 | The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse |
| Q34132638 | The role of κ-opioid receptor activation in mediating antinociception and addiction |
| Q37192749 | Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid |
| Q37455456 | kappa-Opioid receptor signaling and brain reward function |
| Q26864309 | κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction |
Search more.